This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated TRPA1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-TRPA1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~127.5 kDa | |
| Observed band | ~120 kDa | |
| Gel | 8–10% | |
| Negative control | siRNA / KO lysate |
| PTM | Glycosylated | |
| Caveat | Multi-pass membrane protein | |
| Regulation | LPS-suppressed | |
| Isoform | 1 isoform(s) |
Literature-validated Western blot parameters for TRPA1 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | human HEPG2 , Lane 2: human CACO-2 . After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-TRPA1/TSA antigen affinity purified polyclonal antibody (Catalog # A00453-2) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for TRPA1/TSA at approximately 120KD. The expected band size for TRPA1/TSA is at 120KD |
| Gel % | 8–10% |
| Load | 50ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 120 kDa |
TRPA1 has a 127.5 kDa calculated mass but is empirically observed at ~120 kDa, likely from anomalous membrane-protein migration outweighing its N-glycosylation.
| predominant band at ~120 kDa | the empirically confirmed native TRPA1 band, running just below its 127.5 kDa calculated mass |
| band appears broad or slightly diffuse rather than a crisp single line | heterogeneous N-glycosylation at Asn747 and Asn753 adds variable carbohydrate mass across the population of molecules |
| little or no signal in cytosolic-only fractions or non-detergent lysates | TRPA1 is a multi-pass plasma-membrane protein and needs membrane-solubilizing lysis conditions to be released |
| single species with no companion higher- or lower-mass bands | only one TRPA1 isoform is annotated, so no alternative-splicing bands are expected |
| band position essentially unchanged between reducing and non-reducing gels | the five annotated disulfide bonds are intrachain, stabilizing the pore-loop region rather than linking separate subunits |
| predicted backbone mass (127.5 kDa) | sets the baseline unmodified size against which the observed ~120 kDa band is compared |
| N-glycosylation at Asn747 and Asn753 | adds variable carbohydrate mass and can broaden the band into a diffuse smear rather than a sharp uniform shift |
| multi-pass membrane topology | hydrophobic transmembrane segments retain partial structure in SDS-PAGE and commonly cause faster migration (lower apparent kDa) than the calculated mass, matching the ~120 kDa observed band |
| intrachain disulfide bonds stabilizing the pore-loop region | preserved under non-reducing conditions but do not crosslink separate subunits, so band position stays essentially the same with or without reducing agent |
| non-glycosylated bacterial recombinant standard | runs lower than the native ~120 kDa band because it lacks the N-linked glycans present on the endogenous protein |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | sample was extracted without a membrane-solubilizing detergent, leaving this multi-pass membrane channel unreleased | re-lyse in a buffer with 1% Triton X-100 or NP-40 and use whole-cell rather than cytosolic-only fractions |
| Band lower than expected | anomalous SDS-PAGE migration of the hydrophobic transmembrane domains pulls the band below the 127.5 kDa calculated mass | compare against the confirmed ~120 kDa reference band rather than the calculated mass, and run a known-positive lysate alongside |
| Broad smear instead of sharp band | heterogeneous N-glycosylation at Asn747 and Asn753 produces a range of glycoform masses | use a longer gradient gel run or treat a lysate aliquot with PNGase F to collapse the smear to a single deglycosylated species |
| Band higher than expected | incomplete denaturation or aggregation of the hydrophobic membrane protein leaves residual higher-order structure | increase SDS/reducing agent concentration and incubate at 37-55°C instead of full boiling to avoid membrane-protein aggregation |
| Multiple bands | nonspecific antibody cross-reactivity or partial proteolytic degradation during lysis | add protease inhibitors during lysis, confirm identity with a second antibody, and compare against a TRPA1 knockdown control |
| Weak or no signal | native TRPA1 expression is low outside sensory neuron populations | use dorsal root ganglia lysate or an overexpression system as a positive control and increase total protein loaded |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for TRPA1, answered from its protein features.
BosterBio's TRPA1 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
The recommended anti-TRPA1 antibody below represents Boster's best-performing option for Western blot, extensively cited in the literature and thoroughly validated, with specificity confirmed through orthogonal approaches including negative-tissue controls and complementary detection methods to ensure confident, reproducible TRPA1 detection.
Which to pick: Only one Boster anti-TRPA1/TSA antibody (A00453-2) is catalogued here, and it includes an actual Western blot validation image on 5-20% SDS-PAGE, making it the clear, and only, choice for TRPA1 WB detection.